Postpartum Depression: Screening, Diagnosis, and Management Programs 2000 through 2010

The value and appropriateness of universal postpartum depression (PPD) screening remains controversial in the United States. To date, several PPD screening programs have been introduced and a few have been evaluated. Among those programs that have been evaluated, most report screening rates, diagnos...

Full description

Bibliographic Details
Main Authors: Yawn, Barbara P., Olson, Ardis L., Bertram, Susan, Pace, Wilson, Wollan, Peter, Dietrich, Allen J.
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413986/
id pubmed-3413986
recordtype oai_dc
spelling pubmed-34139862012-08-16 Postpartum Depression: Screening, Diagnosis, and Management Programs 2000 through 2010 Yawn, Barbara P. Olson, Ardis L. Bertram, Susan Pace, Wilson Wollan, Peter Dietrich, Allen J. Research Article The value and appropriateness of universal postpartum depression (PPD) screening remains controversial in the United States. To date, several PPD screening programs have been introduced and a few have been evaluated. Among those programs that have been evaluated, most report screening rates, diagnosis rates, or treatment initiation rates. Only four studies included patient outcomes such as the level of depressive symptoms at 6 to 12 months postpartum, and only two reported success in improving outcomes. Program characteristics that appear to result in low rates of diagnosis and followup after PPD screening include requirements for a formal psychiatric evaluation, the need to refer women to another site for therapy, and failure to integrate the PPD screening into the care provided at the woman's or her child's medical home. The two programs that reported improved outcomes were both self-contained within primary care and included specific followup, management, and therapy procedures. Both resulted in the need for outside referrals in less than 10% of women diagnosed with postpartum depression. Future studies should be based on the successful programs and their identified facilitators while avoiding identified barriers. To affect policies, the future program must report maternal outcomes going beyond the often reported process outcomes of screening, referral, and therapy initiation rates. Hindawi Publishing Corporation 2012 2012-07-30 /pmc/articles/PMC3413986/ /pubmed/22900157 http://dx.doi.org/10.1155/2012/363964 Text en Copyright © 2012 Barbara P. Yawn et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Yawn, Barbara P.
Olson, Ardis L.
Bertram, Susan
Pace, Wilson
Wollan, Peter
Dietrich, Allen J.
spellingShingle Yawn, Barbara P.
Olson, Ardis L.
Bertram, Susan
Pace, Wilson
Wollan, Peter
Dietrich, Allen J.
Postpartum Depression: Screening, Diagnosis, and Management Programs 2000 through 2010
author_facet Yawn, Barbara P.
Olson, Ardis L.
Bertram, Susan
Pace, Wilson
Wollan, Peter
Dietrich, Allen J.
author_sort Yawn, Barbara P.
title Postpartum Depression: Screening, Diagnosis, and Management Programs 2000 through 2010
title_short Postpartum Depression: Screening, Diagnosis, and Management Programs 2000 through 2010
title_full Postpartum Depression: Screening, Diagnosis, and Management Programs 2000 through 2010
title_fullStr Postpartum Depression: Screening, Diagnosis, and Management Programs 2000 through 2010
title_full_unstemmed Postpartum Depression: Screening, Diagnosis, and Management Programs 2000 through 2010
title_sort postpartum depression: screening, diagnosis, and management programs 2000 through 2010
description The value and appropriateness of universal postpartum depression (PPD) screening remains controversial in the United States. To date, several PPD screening programs have been introduced and a few have been evaluated. Among those programs that have been evaluated, most report screening rates, diagnosis rates, or treatment initiation rates. Only four studies included patient outcomes such as the level of depressive symptoms at 6 to 12 months postpartum, and only two reported success in improving outcomes. Program characteristics that appear to result in low rates of diagnosis and followup after PPD screening include requirements for a formal psychiatric evaluation, the need to refer women to another site for therapy, and failure to integrate the PPD screening into the care provided at the woman's or her child's medical home. The two programs that reported improved outcomes were both self-contained within primary care and included specific followup, management, and therapy procedures. Both resulted in the need for outside referrals in less than 10% of women diagnosed with postpartum depression. Future studies should be based on the successful programs and their identified facilitators while avoiding identified barriers. To affect policies, the future program must report maternal outcomes going beyond the often reported process outcomes of screening, referral, and therapy initiation rates.
publisher Hindawi Publishing Corporation
publishDate 2012
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413986/
_version_ 1611548231444987904